Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent Deferred RevenueCurrent LeasesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueEBIATGross ProfitLeasesOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetReceivables - OtherShares IssuedShares OutstandingShares OutstandingWages, Salaries and Other
Ratios

Apyx Medical (APYX) Receivables - Other (2018 - 2025)

Apyx Medical filings provide 9 years of Receivables - Other readings, the most recent being $300000.0 for Q4 2025.

  • On a quarterly basis, Receivables - Other fell 25.0% to $300000.0 in Q4 2025 year-over-year; TTM through Dec 2025 was $300000.0, a 25.0% decrease, with the full-year FY2025 number at $300000.0, down 25.0% from a year prior.
  • Receivables - Other hit $300000.0 in Q4 2025 for Apyx Medical, down from $400000.0 in the prior quarter.
  • In the past five years, Receivables - Other ranged from a high of $1.4 million in Q2 2021 to a low of $19000.0 in Q3 2022.
  • Median Receivables - Other over the past 5 years was $458500.0 (2021), compared with a mean of $511500.0.
  • Biggest five-year swings in Receivables - Other: tumbled 97.82% in 2022 and later surged 3036.84% in 2023.
  • Apyx Medical's Receivables - Other stood at $500000.0 in 2021, then increased by 20.0% to $600000.0 in 2022, then decreased by 16.67% to $500000.0 in 2023, then decreased by 20.0% to $400000.0 in 2024, then fell by 25.0% to $300000.0 in 2025.
  • The last three reported values for Receivables - Other were $300000.0 (Q4 2025), $400000.0 (Q4 2024), and $500000.0 (Q4 2023) per Business Quant data.